• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度脂蛋白:在 COPD 中的炎症作用。

High-Density Lipoproteins: A Role in Inflammation in COPD.

机构信息

Department of Nursing, Ryazan State Medical University, 390026 Ryazan, Russia.

出版信息

Int J Mol Sci. 2022 Jul 23;23(15):8128. doi: 10.3390/ijms23158128.

DOI:10.3390/ijms23158128
PMID:35897703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9331387/
Abstract

Chronic obstructive pulmonary disease (COPD) is a widespread disease associated with high rates of disability and mortality. COPD is characterized by chronic inflammation in the bronchi as well as systemic inflammation, which contributes significantly to the clinically heterogeneous course of the disease. Lipid metabolism disorders are common in COPD, being a part of its pathogenesis. High-density lipoproteins (HDLs) are not only involved in lipid metabolism, but are also part of the organism's immune and antioxidant defense. In addition, HDL is a versatile transport system for endogenous regulatory agents and is also involved in the removal of exogenous substances such as lipopolysaccharide. These functions, as well as information about lipoprotein metabolism disorders in COPD, allow a broader assessment of their role in the pathogenesis of heterogeneous and comorbid course of the disease.

摘要

慢性阻塞性肺疾病(COPD)是一种广泛存在的疾病,与高残疾率和高死亡率相关。COPD 的特征是支气管慢性炎症和全身炎症,这对疾病的临床异质性过程有重要贡献。脂代谢紊乱在 COPD 中很常见,是其发病机制的一部分。高密度脂蛋白(HDL)不仅参与脂质代谢,还是机体免疫和抗氧化防御的一部分。此外,HDL 是内源性调节因子的多功能转运系统,也参与外源性物质如脂多糖的清除。这些功能以及关于 COPD 中脂蛋白代谢紊乱的信息,使得我们能够更全面地评估它们在疾病异质性和合并症发病机制中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/9331387/2dee8e47ffc9/ijms-23-08128-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/9331387/b165baa8f8c9/ijms-23-08128-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/9331387/46b6b2abade6/ijms-23-08128-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/9331387/2dee8e47ffc9/ijms-23-08128-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/9331387/b165baa8f8c9/ijms-23-08128-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/9331387/46b6b2abade6/ijms-23-08128-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/9331387/2dee8e47ffc9/ijms-23-08128-g003.jpg

相似文献

1
High-Density Lipoproteins: A Role in Inflammation in COPD.高密度脂蛋白:在 COPD 中的炎症作用。
Int J Mol Sci. 2022 Jul 23;23(15):8128. doi: 10.3390/ijms23158128.
2
High-Density Lipoproteins and Apolipoprotein A1.高密度脂蛋白与载脂蛋白A1
Subcell Biochem. 2020;94:399-420. doi: 10.1007/978-3-030-41769-7_16.
3
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!高密度脂蛋白与炎症的相互作用:功能比浓度更重要!
Adv Drug Deliv Rev. 2020;159:94-119. doi: 10.1016/j.addr.2020.10.006. Epub 2020 Oct 17.
4
Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.载脂蛋白 A-I 可改善胰腺 β 细胞功能,而不依赖于三磷酸腺苷结合盒转运体 ABCA1 和 ABCG1。
FASEB J. 2019 Jul;33(7):8479-8489. doi: 10.1096/fj.201802512RR. Epub 2019 Apr 10.
5
The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality.高密度脂蛋白(HDL)研究现状:从 HDL 数量到 HDL 质量和功能的范式转变。
Int J Mol Sci. 2022 Apr 2;23(7):3967. doi: 10.3390/ijms23073967.
6
The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.人载脂蛋白A-I的C末端螺旋在高密度脂蛋白颗粒形成中的作用。
Biochim Biophys Acta. 2014 Jan;1841(1):80-7. doi: 10.1016/j.bbalip.2013.10.005. Epub 2013 Oct 9.
7
ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.ABCA1 依赖的脂质外流至载脂蛋白 A-I 介导高密度脂蛋白颗粒形成并减少小鼠肝细胞极低密度脂蛋白的分泌。
J Lipid Res. 2004 Jun;45(6):1122-31. doi: 10.1194/jlr.M300529-JLR200. Epub 2004 Mar 1.
8
Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I.载脂蛋白结合的脂类在酪氨酸自由基氧化的高密度脂蛋白中稳定 ABCA1 就像无脂载脂蛋白 A-I 一样。
BMC Biochem. 2012 Jan 16;13:1. doi: 10.1186/1471-2091-13-1.
9
Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.在CETP转基因大鼠中表达人载脂蛋白A-I会导致高密度脂蛋白中载脂蛋白C-I水平降低,并放大CETP介导的脂蛋白变化。
J Lipid Res. 2006 Feb;47(2):356-65. doi: 10.1194/jlr.M500288-JLR200. Epub 2005 Nov 10.
10
On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway.ABCA1/载脂蛋白A-I途径介导的高密度脂蛋白组装的肝脏机制
J Lipid Res. 2005 Jan;46(1):154-62. doi: 10.1194/jlr.M400402-JLR200. Epub 2004 Nov 1.

引用本文的文献

1
From COPD to Smoke-Related Arteriopathy: The Mechanical and Immune-Inflammatory Landscape Underlying Lung Cancer Distant Spreading-A Narrative Review.从慢性阻塞性肺疾病到与吸烟相关的动脉病变:肺癌远处转移背后的机械及免疫炎症图景——一篇综述
Cells. 2025 Aug 8;14(16):1225. doi: 10.3390/cells14161225.
2
Associations between serum lipid profiles and the incidence of chronic obstructive pulmonary disease in the UK Biobank.英国生物银行中血清脂质谱与慢性阻塞性肺疾病发病率之间的关联。
J Health Popul Nutr. 2025 Aug 6;44(1):281. doi: 10.1186/s41043-025-01026-7.
3
The higher serum uric acid to high-density lipoprotein cholesterol ratio is associated with increased risk of chronic obstructive pulmonary disease: result from NHANES 2011-2018.

本文引用的文献

1
Prevalence of metabolic syndrome in chronic obstructive pulmonary disease and its correlation with severity of disease.慢性阻塞性肺疾病中代谢综合征的患病率及其与疾病严重程度的相关性。
J Family Med Prim Care. 2022 May;11(5):2094-2098. doi: 10.4103/jfmpc.jfmpc_1640_21. Epub 2022 May 14.
2
The lipid ties of α1-antitrypsin: Structural and functional aspects.α1-抗胰蛋白酶的脂质联系:结构与功能方面
Cell Immunol. 2022 May;375:104528. doi: 10.1016/j.cellimm.2022.104528. Epub 2022 Apr 16.
3
Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States.
血清尿酸与高密度脂蛋白胆固醇比值升高与慢性阻塞性肺疾病风险增加相关:来自2011 - 2018年美国国家健康与营养检查调查的结果
BMC Pulm Med. 2025 Jul 4;25(1):322. doi: 10.1186/s12890-025-03743-5.
4
Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.脂质代谢与免疫功能的关联:慢性呼吸道疾病的新见解
Pathophysiology. 2025 Jun 6;32(2):26. doi: 10.3390/pathophysiology32020026.
5
Prognostic Value of Apolipoprotein E in Predicting One-year Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.载脂蛋白E在预测慢性阻塞性肺疾病急性加重患者一年死亡率中的预后价值
Int J Chron Obstruct Pulmon Dis. 2025 May 23;20:1639-1650. doi: 10.2147/COPD.S512096. eCollection 2025.
6
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and preserved ratio impaired spirometry: NHANES 2007-2012.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与肺量计测定的保留率受损之间的关联:2007 - 2012年美国国家健康与营养检查调查
Lipids Health Dis. 2025 Apr 25;24(1):157. doi: 10.1186/s12944-025-02571-0.
7
Association Between the Non-High-Density Lipoprotein Cholesterol-to-High-Density Lipoprotein Cholesterol Ratio (NHHR) and Mortality in Patients with COPD: Evidence From the NHANES 1999-2018.慢性阻塞性肺疾病(COPD)患者非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与死亡率之间的关联:来自1999 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Int J Chron Obstruct Pulmon Dis. 2025 Mar 28;20:857-868. doi: 10.2147/COPD.S508481. eCollection 2025.
8
Causal Correlations Between Plasma Metabolites, Inflammatory Proteins, and Chronic Obstructive Pulmonary Disease: A Mendelian Randomization and Bioinformatics-Based Investigation.血浆代谢物、炎症蛋白与慢性阻塞性肺疾病之间的因果关系:基于孟德尔随机化和生物信息学的研究
J Inflamm Res. 2025 Mar 18;18:4057-4073. doi: 10.2147/JIR.S513526. eCollection 2025.
9
Association between monocyte-high-density lipoprotein cholesterol ratio and mortality in a population with asthma: a cohort study.哮喘人群中单核细胞与高密度脂蛋白胆固醇比值与死亡率的关联:一项队列研究
Lipids Health Dis. 2025 Feb 21;24(1):59. doi: 10.1186/s12944-025-02484-y.
10
Causal Relationships Between Blood Lipid Levels and Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Analysis.血脂水平与慢性阻塞性肺疾病之间的因果关系:一项孟德尔随机化分析
Int J Chron Obstruct Pulmon Dis. 2025 Jan 8;20:83-93. doi: 10.2147/COPD.S476833. eCollection 2025.
单核细胞-高密度脂蛋白胆固醇比值(MHR)与全因和心血管死亡率的关系:美国全国队列研究。
Lipids Health Dis. 2022 Mar 18;21(1):30. doi: 10.1186/s12944-022-01638-6.
4
Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.全球、区域和国家 2019 年慢性阻塞性肺疾病(COPD)的患病率、危险因素:系统评价和建模分析。
Lancet Respir Med. 2022 May;10(5):447-458. doi: 10.1016/S2213-2600(21)00511-7. Epub 2022 Mar 10.
5
ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis.ABCA1 和 ABCG1 作为预防动脉粥样硬化的潜在治疗靶点。
J Pharmacol Sci. 2022 Feb;148(2):197-203. doi: 10.1016/j.jphs.2021.11.005. Epub 2021 Dec 1.
6
Involvement of the Innate Immune System in the Pathogenesis of Chronic Obstructive Pulmonary Disease.固有免疫系统在慢性阻塞性肺疾病发病机制中的作用。
Int J Mol Sci. 2022 Jan 17;23(2):985. doi: 10.3390/ijms23020985.
7
Epidemiological evidence relating risk factors to chronic obstructive pulmonary disease in China: A systematic review and meta-analysis.中国与慢性阻塞性肺疾病相关危险因素的流行病学证据:系统评价和荟萃分析。
PLoS One. 2021 Dec 28;16(12):e0261692. doi: 10.1371/journal.pone.0261692. eCollection 2021.
8
Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink.慢性阻塞性肺疾病患者他汀类药物处方与加重风险:临床实践研究数据库中的回顾性队列研究。
BMJ Open. 2021 Dec 7;11(12):e050757. doi: 10.1136/bmjopen-2021-050757.
9
Bioinformatic Analysis of Gene Expression in Smoking and Chronic Obstructive Pulmonary Disease.吸烟与慢性阻塞性肺疾病中基因表达的生物信息学分析
Membranes (Basel). 2021 Aug 31;11(9):674. doi: 10.3390/membranes11090674.
10
Prediction of cardiovascular risk in patients with chronic obstructive pulmonary disease: a study of the National Health and Nutrition Examination Survey database.慢性阻塞性肺疾病患者心血管风险预测:国家健康和营养调查数据库研究。
BMC Cardiovasc Disord. 2021 Sep 1;21(1):417. doi: 10.1186/s12872-021-02225-w.